# Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide

> **NCT00796159** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1723 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Olmesartan medoxomil

## Key facts

- **NCT ID:** NCT00796159
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 1723 (ACTUAL)
- **Last updated:** 2009-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796159, "Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00796159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*